Amphastar Pharmaceuticals, Inc. (AMPH)
↓ Download CSV- Sector Manufacturing
- Fiscal year ends Dec 31
In fiscal 2025, Amphastar Pharmaceuticals, Inc. reported revenue of $719.89M, down 1.7% from the prior year. The company was profitable, with a net margin of 13.6% and a gross margin of 49.5%. It held $1.63B in total assets against $840.49M in total liabilities.
Key ratios (FY2025)
49.5%
Gross margin
19.5%
Operating margin
13.6%
Net margin
12.4%
Return on equity
-1.7%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $719.89M | $731.97M | $644.39M | $498.99M | $437.77M | $349.85M | $322.36M | $294.67M | $240.18M | $255.16M |
| Cost of Revenue | $363.83M | $358.11M | $293.27M | $250.13M | $238.03M | $206.51M | $190.43M | $187.68M | $149.67M | $150.97M |
| Gross Profit | $356.06M | $373.86M | $351.12M | $248.86M | $199.74M | $143.34M | $131.92M | $106.98M | $90.51M | $104.20M |
| Operating Income | $140.40M | $205.42M | $196.99M | $107.50M | $69.89M | $10.95M | -$39.0K | -$8.62M | -$1.27M | $15.38M |
| Net Income | $98.09M | $159.52M | $137.54M | $91.39M | $62.12M | $1.40M | $48.94M | -$5.74M | $3.65M | $9.82M |
| EPS (Diluted) | $2.03 | $3.06 | $2.60 | $1.74 | $1.25 | $0.03 | $0.98 | $-0.12 | $0.08 | $0.21 |
| Total Assets | $1.63B | $1.58B | $1.51B | $741.99M | $671.53M | $631.24M | $586.97M | $513.56M | $451.07M | $427.74M |
| Total Liabilities | $840.49M | $845.17M | $873.49M | $213.33M | $226.01M | $182.51M | $159.44M | $149.20M | $117.34M | $98.48M |
| Shareholders' Equity | $788.80M | $732.30M | $639.42M | $528.66M | $445.52M | $448.72M | $427.53M | $364.36M | $333.74M | $326.52M |
| Cash & Equivalents | $170.18M | $151.61M | $144.30M | $156.10M | $126.35M | $92.64M | $73.69M | $86.34M | $65.59M | $72.35M |
| Operating Cash Flow | $156.12M | $213.39M | $183.50M | $89.18M | $97.99M | $57.27M | $41.76M | $38.19M | $39.21M | $38.56M |
| Capital Expenditures | $34.88M | $41.04M | $38.17M | $24.03M | $27.46M | $33.85M | $41.55M | $46.81M | $35.10M | $21.38M |
| Shares Outstanding | 48.22M | 52.06M | 53.00M | 52.43M | 49.78M | 49.12M | 49.91M | 46.40M | 48.37M | 47.50M |